Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
New York City, United States
Countries of investment
  • United States
  • Canada
  • United Kingdom
  • Netherlands
  • Singapore
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
  • Growth
Industries
  • Technology
  • Machine Learning
  • Robotics
About
Lux Capital is a venture capital firm that partners with visionary entrepreneurs at the intersection of science and technology, backing transformative companies in areas such as space, robotics, AI, and life sciences.
Min check size
$100K
Max check size
$5M
Fund size
NPS

Investment Thesis

Lux Capital is a venture firm backing frontier science and emerging-technology companies, especially in biotech, AI, robotics, aerospace, advanced manufacturing, and deep tech. It invests across early to growth stages, partnering with iconoclastic founders to transform high-science breakthroughs into impactful businesses. Its Lux Labs initiative further supports early-stage academic research, committing substantial capital to build companies directly from university labs and underfunded scientific discoveries.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Lux Capital, established in 2000 by Peter Hébert, Robert Paull, and Josh Wolfe, broadened its leadership team with high-profile additions such as former McKinsey Senior Partner Richard N. Foster, former CIA Director James Woolsey, and ex-Pfizer CEO Jeff Kindler, combining investment expertise with top-level operating experience.

Lux Capital Contacts Information

Primary contact

Secondary contact

Team

Peter Hébert – Partner and Co-Founder

Josh Wolfe – Partner and Co-Founder

Steven Brody – Partner

Portfolio

Anduril

Applied Intuition

Hugging Face

Runway

Eikon Therapeutics

Databricks

Aera

Cognition

Kallyope

Osmo

Matterport

Benchling

Hadrian

Saildrone

Ramp

Ironclad

Openspace

Recursion Pharma

Maven

Auris Health

Sakana

Chronosphere

Evolutionary Scale

and Physical Intelligence.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp